Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-29

Clinical Trial Update: Assessment of Long-Term Infliximab for Psoriasis (P05319)

View source ↗

Summary

This entry reports the long-term evaluation of infliximab for psoriasis in a completed clinical trial, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis | Status: COMPLETED | Results posted: 2012-10-29